COVID-19 in prisons: understanding the spread of the disease
Since the start of the pandemic, COVID-19 rates in Canadian correctional facilities have been...
RI-MUHC researchers support Canada’s efforts to address the COVID-19 pandemic
Drs. Emily McDonald and Todd C. Lee are part of the Canadian Network of COVID-19 Clinical Trials Networks...
Zombie cells and flu fighters
Research by postdoc Hosni Cherif and Dr. Inés Colmegna makes Arthritis Society’s Top 10 breakthroughs
Overcoming vaccine hesitancy
Our best hope of charting a course to a post-pandemic world
New study of hydroxychloroquine usage may help personalize lupus treatment
RI-MUHC researchers identify factors associated with poor outcomes for lupus patients
Two studies confirm efficiency of saliva tests for COVID-19
Testing is the cornerstone of the fight against COVID-19, and a test that can be self-administered would greatly increase the options for case...
Could an antidepressant slow COVID-19 progression?
RI-MUHC researchers launch a clinical trial of fluvoxamine, a drug that has already proven efficient in reducing lung injury in animal studies and...
RI-MUHC researcher Nitika Pant Pai advocates improved access to HIV self-testing for Canadians
Canada approves HIV self-testing kit ahead of World AIDS Day 2020
Driving Personalized Medicine: The 2020 RI-MUHC Annual Report is online!
An invitation from Dr. Miguel Burnier Jr.
Paving the way for COVID-19 research
RI-MUHC and McGill Containment level 3 Labs receive $1M in funding to accelerate research with live SARS Cov-2